Global Health is set to convene a Board of Directors meeting on February 4, 2026, to review and potentially approve the unaudited financial results for Q3 (Oct-Dec) and the nine-month period ending December 31, 2025. The company has initiated an insider trading window closure starting January 1, 2026, to ensure compliance. The window will reopen 48 hours after the results are declared.
Upcoming Board Meeting
Global Health has announced an upcoming meeting of its Board of Directors scheduled for February 4, 2026. The primary agenda is to consider and approve the unaudited financial results for the third quarter (Q3: Oct-Dec) of FY26 and the nine-month period ending on December 31, 2025.
Insider Trading Window Closure
In compliance with regulations regarding insider trading, Global Health has already closed its trading window effective January 1, 2026. This measure ensures that individuals with access to unpublished price-sensitive information are restricted from trading in the company’s securities until the financial results are publicly disclosed. The trading window will re-open 48 hours after the official declaration of the aforementioned results.
Source: BSE
